Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

AGTC presents positive data from ongoing phase I/II clinical program in XLRP

Nov. 12, 2020

Phase II/III study of voclosporin ophthalmic solution in dry eye does not meet primary endpoint

Nov. 4, 2020

University of Massachusetts presents factor H vectors

Oct. 30, 2020

Aerie initiates phase IIb COMET-1 trial of AR-15512 ophthalmic solution

Oct. 29, 2020

Positive data presented from phase III GEMINI 1 and 2 studies of AGN-190584

Oct. 29, 2020

Positive topline data from phase I/IIa study of IVMED-80 eyedrops

Oct. 29, 2020

FDA approves Eysuvis for short-term treatment of dry eye disease

Oct. 28, 2020

FDA approves IND for phase II study of VSJ-110 for allergic conjunctivitis

Oct. 27, 2020

Gene therapy approaches tackle multiple forms of blindness

Oct. 22, 2020

Apellis reports 18-month data on pegcetacoplan in advanced geographic atrophy

Oct. 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...